Ying Lu

机构：Ningbo University, Ningbo University Affiliated Hospital · ORCID：0000-0001-7922-1268

发表论文 63 篇 · 总被引 378 次 · h-index 9

代表论文

• NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia (2024 · Journal of Translational Medicine · 被引 4)
• Flavokawain a induces cell cycle arrest through CDT1-dependent p27 regulation and synergizes with venetoclax in acute myeloid leukemia (2025 · Toxicology and Applied Pharmacology · 被引 3)
• The novel HLA‐B*38:103N allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual (2024 · HLA · 被引 3)
• Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab (2024 · Transfusion · 被引 3)
• Acute and Persistent Remission of Aggressive Natural Killer Cell Leukemia in an Older Patient Induced by Chidamide Combined with Cyclophosphamide, Vindesine, Prednisone, and Etoposide Therapy (2023 · Turkish Journal of Hematology · 被引 3)
• Signatures of tumor microenvironment-related genes and long noncoding RNAs predict poor prognosis in osteosarcoma (2025 · PLoS ONE · 被引 2)